Galindo Alejandro
- SEC CIK
- 0001821447
No open-market purchases or sales filed in the past year.
Current role at each company
- MNKD Mannkind CorpEVP Endocrine Business Unitas of Aug 24, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Galindo Alejandro as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 23, 2022 (view filing) | Aug 22 | 1 day | Galindo AlejandroEVP Endocrine Business Unit | SSaleCommon Stock, $0.01 Par Value | −4.62K | $3.85 | −$17.8K | −0.6%777.1K after | 2 lots |
| Aug 2, 2021 (view filing) | Jul 30 | 3 days | Galindo AlejandroChief Commercial Officer | PPurchaseCommon Stock, $0.01 Par Value | +5.00K | $2.99 | +$14.9K | +0.9%547.6K after |